Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab

Abstract

The emergence of new extrahepatic lesions in the second-line setting is a poor prognostic factor for post-progression survival. The benefit of ramucirumab for overall survival was consistent across progression patterns.